Aktiespot

Tandem Diabetes Care, Inc. (Tandem Diabetes Care Inc. R) aksje

TD5A.F

€15.60+1.10 (+7.59%)
Laster graf...

Tandem Diabetes Care Inc. R

Åpning15.20
Høy16.40
Lav15.20
Volum253
P/EN/A
Markedsverdi1.07B
52-ukers høy23.09
52-ukers lav8.79
Gj.sn. volum45
UtbytteN/A
Beta1.64
EPS-1.18

Om Tandem Diabetes Care, Inc. (Tandem Diabetes Care Inc. R) aksje

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Selskapsinformasjon

Børs: Frankfurt (FRA)
Sektor: Sundhed
Industri: Medicinsk udstyr
Adresse:
12400 High Bluff Drive
92130 San Diego, United States
Telefon: + 858 366 6900

Analytikernes aksjeanbefalinger

Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.

Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål

Andre ser også på: